Abeona Therapeutics (NASDAQ:ABEO) executives said the company is seeing growing patient demand for ZEVASKYN, an autologous cell-based gene therapy approved in April 2025 for adults and pediatric ...

BASED cleanroom engineering company Total Clean Air (TCA), a UKAS ISO 17025-accredited cleanroom constructor, has been appointed European partner for US-based decontamination technology firm ...

Abeona Therapeutics Inc (ABEO) reports growing patient demand and significant financial gains, despite facing operational hurdles in launching its groundbreaking gene therapy.

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2025 Earnings Call Transcript March 17, 2026 Abeona Therapeutics Inc. beats ...

Good morning, everyone, and welcome to the Abeona Therapeutics Full Year 2025 Results Conference Call. [Operator Instructions] Please note this conference is being recor ...

Abeona Therapeutics has made significant strides in the fourth quarter of 2025, with its groundbreaking gene therapy, ZEVASKYN, experiencing growing patient demand. As reported during the company's ...

Peptides come in creams and pills, but injections are most common because that enables the compounds to bypass digestion, making it easier for your body to use.  Some peptide-based products are well ...

To address these critical safety requirements, BETMAT Biotechnology LLC has released a specialized operational guide focused on Reliable Endotoxin Testing For Injectable Pharmaceuticals, a systematic ...

SONOTEC, a specialist in ultrasonic technology, will show its high accuracy flow meters and bubble detectors at Single-Use ...

In this prominent people in packaging interview, Paul Marshall from Zimmer Biomet reflects on balancing innovation and patient safety.

The Citizens Life Sciences Conference 2026 March 11, 2026 1:40 PM EDTCompany ParticipantsSteven Harr - President, CEO ...

In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a future thought impossible.